Co-Authors
This is a "connection" page, showing publications co-authored by Makoto Takeda and Yasushi Kawaguchi.
Connection Strength
0.098
-
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Viruses. 2020 06 10; 12(6).
Score: 0.055
-
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. Antimicrob Agents Chemother. 2016 11; 60(11):6532-6539.
Score: 0.043